Thanks to four workshops, several reports and direct experiences reported by the participants, MLS® carved out a significant role in the 2014 edition of the Annual Conference by BioResearch, ASAlaser’s partner in the U.S. for the distribution of Laser Therapy applied to dental field. In the spaces of "La Marquette" University in Milwaukee, scenography of the meeting, the participants have in fact verified the results achievable with MLS® thanks to some focuses dedicated to the application of the therapy in orthodontics, in the treatment of pain and temporo-mandibular joint dysfunction and in the reduction of inflammations.
Significant have been also the participation of some professionals who have completed the range of theoretical and practical knowledge of ASAlaser's therapeutic proposal: Dr. Brock Rondeau has led the section "Practice Building with BIOPACK and Mphi" and Michael Smith has issued guidance on the use of both BioPak System by Bioresearch for diagnosing problems related to TMD, and of MLS®, demonstrating the advantages, in the daily practice, of using a combination of diagnosis-therapy, coining the phrase "Technology for Case Perfection". «During the section "Mentor Appointment" - explains Lucio Zaghetto, ASAlaser CEO – I’ve met some of our customers, excited about the results obtained with MLS®. They have emphasized not only its ability to cure quickly and effectively, but also the feedback of some patients incredulous about the rate of disappearance of the pain». Particular interest also aroused the presentation of the latest researches carried out by ASAlaser to document the mechanisms of action of the therapy. «We are proud of our scientific and commercial results - concludes Zaghetto – because they are a tangible proof of the correct choices made by the Company in terms of research, training, technology and communication. Choices that allow us to be recognized leaders even in particularly complex markets such as the U.S. one, always considered to be a landmark on an international scale».
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.